SCHEMBL8307070

SCHEMBL8307070

COc1ccc(C(C)=NOCCO)cn1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NNMT P40261 2/20 0.46
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
MET P08581 5/20 0.38
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PTBP1 P26599 1/20 0.37
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE3B Q13370 4/20 0.36
PDE3A Q14432 4/20 0.36
MAPT P10636 2/20 0.36
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GPR183 P32249 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8307069 1.00 NNMT (0.46) NNMTMKNK1MKNK2METLMNA
SCHEMBL8309510 0.87 MAPT (0.51) METLMNASMN1; SMN2PTBP1MAPK1
SCHEMBL8309507 0.87 MAPT (0.51) METLMNASMN1; SMN2PTBP1MAPK1
SCHEMBL14277946 0.86 ESR1 (0.46) NNMTMKNK1MKNK2SMN1; SMN2MAPT
SCHEMBL8305073 0.85 MET (0.36) METLMNASMN1; SMN2PTBP1MAPK1
SCHEMBL8305075 0.85 MET (0.36) METLMNASMN1; SMN2PTBP1MAPK1
SCHEMBL4317630 0.79 L3MBTL1 (0.48) NNMTLMNASMN1; SMN2MAPK1HTT
SCHEMBL4317633 0.79 L3MBTL1 (0.48) NNMTLMNASMN1; SMN2MAPK1HTT
SCHEMBL8304541 0.76 PPARG (0.54) METLMNASMN1; SMN2MAPK1HTT
SCHEMBL8304542 0.76 PPARG (0.54) METLMNASMN1; SMN2MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed